Performance of the Vitek 2, Sensititre, and Etest antimicrobial susceptibility testing systems for isolates of <i>Burkholderia cepacia</i> complex. [PDF]
Shier KL +4 more
europepmc +1 more source
Optimal vancomycin AUC<sub>24</sub>/MIC ratio for predicting clinical outcomes in patients with glycopeptide-susceptible Enterococcus faecium bacteremia. [PDF]
Yamaguchi R +9 more
europepmc +1 more source
J-AST: a web-based analysis platform for antimicrobial susceptibility testing
Figge M +4 more
europepmc +1 more source
A testing time for gradient strips: an evaluation of ETEST for the antimicrobial susceptibility testing of <i>Neisseria gonorrhoeae</i>. [PDF]
Pitt-Kendall R +6 more
europepmc +1 more source
Six-month surveillance of <i>Candida parapsilosis</i> in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance. [PDF]
Steixner S +4 more
europepmc +1 more source
Gim3 buffers and potentiates de novo mutations that affect fluconazole susceptibility in yeast. [PDF]
Tawfeeq MT +8 more
europepmc +1 more source
Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective. [PDF]
Bonomo RA, Hujer AM.
europepmc +1 more source
Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for <i>Candida kefyr</i> Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B. [PDF]
Asadzadeh M +4 more
europepmc +1 more source
Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and Doxycycline. [PDF]
Liu L +6 more
europepmc +1 more source
<i>Candida parapsilosis</i> and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? [PDF]
Vahedi-Shahandashti R +2 more
europepmc +1 more source

